Wilson Bank Holding Company (WBHC)

Theseus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	245.31	247.59	252.64	104.79	453.42	34.11
Investment Securities	893.69	373.7	394.05	378.37	435.81	621.5
Trading Asset Securities	-	0.06	0.07	0.19	0.66	0.71
Mortgage-Backed Securities	-	454.2	417.03	444.44	461.78	263.79
Total Investments	893.69	827.95	811.15	823	898.25	886.01
Gross Loans	4,288	4,106	3,609	3,168	2,496	2,331
Allowance for Loan Losses	-53.85	-49.5	-44.85	-39.81	-39.63	-38.54
Other Adjustments to Gross Loans	-	-13.7	-13.08	-14.15	-12.02	-9.3
Net Loans	4,234	4,042	3,551	3,114	2,444	2,283
Property, Plant & Equipment	62.99	66.99	68.06	68.77	66.96	62.03
Goodwill	5.88	4.81	4.81	4.81	4.81	4.81
Loans Held for Sale	5.09	2.53	2.29	3.36	11.84	19.47
Accrued Interest Receivable	18.87	16.91	15.2	11.4	7.64	7.52
Long-Term Deferred Tax Assets	40.44	46.05	45.47	51.32	12.79	7.09
Other Long-Term Assets	125.42	99.56	92.75	100.07	84.52	60.73
Total Assets	5,632	5,359	4,846	4,286	3,990	3,370
Accrued Expenses	-	3.52	3.3	3.02	2.71	2.3
Interest Bearing Deposits	4,645	3,659	3,418	3,240	2,990	2,446
Institutional Deposits	-	788.22	559.29	238.14	131.92	123.02
Non-Interest Bearing Deposits	394.58	383.17	389.73	414.91	433.5	391.36
Total Deposits	5,040	4,830	4,367	3,893	3,555	2,961
Short-Term Borrowings	-	-	0.01	-	-	0.05
Current Portion of Long-Term Debt	-	-	-	-	-	1.35
Current Portion of Leases	-	0.69	0.65	0.69	0.54	-
Accrued Interest Payable	61.09	39.58	40.67	22.59	13.85	18.95
Federal Home Loan Bank Debt, Long-Term	-	-	-	-	-	2.29
Long-Term Leases	-	5.14	5.34	6.2	3.7	3.95
Total Liabilities	5,101	4,879	4,417	3,925	3,576	2,989
Common Stock	24	23.75	23.37	22.94	22.4	21.99
Additional Paid-In Capital	159.61	150.74	136.87	122.3	105.18	93.03
Retained Earnings	416.84	393.24	357.26	325.63	292.45	257.94
Comprehensive Income & Other	-69.49	-88.23	-88.16	-110.43	-6.32	7.17
Total Common Equity	530.96	479.5	429.34	360.44	413.72	380.12
Minority Interest	-	0.2	0.07	0.02	-	-
Shareholders' Equity	530.96	479.7	429.41	360.45	413.72	380.12
Total Liabilities & Equity	5,632	5,359	4,846	4,286	3,990	3,370
Total Debt	-	5.83	6	6.89	4.25	7.64
Net Cash (Debt)	245.31	241.82	246.7	98.09	449.83	331.93
Net Cash Growth	29.30%	-1.98%	151.51%	-78.20%	35.52%	147.95%
Net Cash Per Share	20.53	20.43	21.19	8.60	40.30	30.30
Filing Date Shares Outstanding	12.13	11.99	11.78	11.57	11.31	11.08
Total Common Shares Outstanding	12	11.88	11.69	11.47	11.2	10.99
Book Value Per Share	44.24	40.37	36.74	31.42	36.93	34.58
Tangible Book Value	525.08	474.7	424.53	355.63	408.91	375.32
Tangible Book Value Per Share	43.76	39.97	36.33	31.00	36.51	34.14

Source: S&P Global Market Intelligence. Banks template. Financial Sources.